Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,047,703 papers from all fields of science
Search
Sign In
Create Free Account
Early-Stage Breast Carcinoma
Known as:
early-stage breast cancer
Breast carcinoma that has not spread beyond the breast and the axillary lymph nodes.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Breast
Epithelial Cells
Epithelium
Limited stage (cancer stage)
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract P2-13-01: Efficacy of neratinib in hormone receptor-positive patients who initiated treatment within 1 year of completing trastuzumab-based adjuvant therapy in HER2+ early-stage breast…
M. Gnant
,
M. Martín
,
+26 authors
B. Ejlertsen
Poster Session Abstracts
2019
Corpus ID: 86586937
Background: The international, randomized, placebo-controlled phase III ExteNET trial showed that 1 year (yr) of neratinib 240 mg…
Expand
2017
2017
Abstract P2-11-03: Incidence and severity of diarrhea with neratinib + intensive loperamide prophylaxis in patients (pts) with HER2+ early-stage breast cancer (EBC): Interim analysis from the…
C. Barcenas
,
E. Olek
,
+18 authors
S. Moran
2017
Corpus ID: 79027591
Background: Neratinib (Puma Biotechnology Inc) is an irreversible pan-HER inhibitor in late-phase development for the treatment…
Expand
Review
2013
Review
2013
Abstract P6-06-02: Direct comparison of risk classification between MammaPrint®, Oncotype DX® and MammoStrat® assays in patients with early stage breast cancer
S. Shivers
,
Laura Clark
,
+14 authors
C. Cox
2013
Corpus ID: 72291993
Several genomic tests for the prediction of breast cancer recurrence are commercially available and their clinical use is…
Expand
2010
2010
Early discontinuation of tamoxifen and aromatase inhibitors (AIs) by postmenopausal women with early-stage breast cancer.
J. Charlson
,
T. Hedin
,
R. Sparapani
,
Chang-Bin Guo
,
A. Nattinger
2010
Corpus ID: 74153448
524 Background: In women with early stage, hormone responsive breast cancer, compliance with adjuvant endocrine therapy is…
Expand
2007
2007
Re: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.
Mevlut Kurt
,
K. Altundağ
Journal of the National Cancer Institute
2007
Corpus ID: 31182973
We read with interest the article by Chlebowski et al. (1), in which the authors investigated the effect of a dietary…
Expand
Review
2007
Review
2007
Crunch time for multiple-gene tests
V. Gewin
Nature
2007
Corpus ID: 8925588
January 2007 January 2006 St oc k pr ic e (U S$ ) For many of the women who will learn this year that they have early-stage…
Expand
2007
2007
Long-term outcome with interstitial brachytherapy boost in thetreatment of women with early-stage breast cancer
R. Neumanová
,
J. Petera
,
T. Frgala
,
L. Dušek
,
J. Jarkovský
,
R. Kuricka
2007
Corpus ID: 221172435
Breast conserving surgery followed by adjuvant radiotherapy and eventually by systemic treatment represent the current trend in…
Expand
2007
2007
Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer.
R. Neumanová
,
J. Petera
,
T. Frgala
,
L. Dušek
,
Jirí Jarkovský
,
R. Kuricka
Neoplasma (Bratislava)
2007
Corpus ID: 32026572
Breast conserving surgery followed by adjuvant radiotherapy and eventually by systemic treatment represent the current trend in…
Expand
2005
2005
The prognostic effect of lipids on early-stage breast cancer (BC) outcome
M. Bahl
,
M. Ennis
,
+4 authors
P. Goodwin
2005
Corpus ID: 53911240
710 Background: The prognosis of women with early-stage BC is affected by certain metabolic factors, namely insulin and body mass…
Expand
Review
2002
Review
2002
Scientific paper Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy
S. Singletary
2002
Corpus ID: 77585307
Background: Patients receiving breast conservation therapy have a lifelong risk of local recurrence. To minimize this risk…
Expand